Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Male and Female Reproductive Disorders
What is the strength of evidence supporting intranasal testosterone use for preserving fertility in hypogonadal men.
Related Questions
What patient profiles or clinical contexts would justify the initiation of elinzanetant (Lynkuet) for postmenopausal vasomotor symptoms, considering its mechanism and current evidence base?
How should PCOS be addressed after menopause?
Is long-term medical management effective for ovarian hyperthecosis, or is surgery the primary treatment option?
In an obese male with low testosterone, would you initiate testosterone replacement therapy at the initial visit, or start tirzepatide first and monitor for improvement in testosterone levels and erectile function?
Can estrogen be given as hormone replacement therapy after surgical menopause to a patient with history of endometriosis ?
Is abnormally elevated estradiol an expected finding in patients with PCOS?
In patients with hypogonadism, when do you recommend subcutaneous over intramuscular testosterone injections?
Can estradiol patches be prescribed once weekly instead of twice weekly for the treatment of postmenopausal symptoms?
Have any studies shown that testosterone replacement therapy lowers the incidence of prostate cancer in hypogonadal men, or is the evidence still largely neutral?
How should we approach the management of PCOS in transgender men seeking virilization?
